An investigation on behalf of investors in NanoViricides, Inc. (NYSE:NNVC) shares over potential wrongdoing at NanoViricides, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 10/15/2020 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at NanoViricides, Inc.
Investors who purchased shares of NanoViricides, Inc. (NYSE: NNVC) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain NanoViricides, Inc. (NYSE: NNVC officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Shelton, CT based NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.
Shares of NanoViricides, Inc. (NYSE: NNVC) spiked from under $2 per share in mid December 2019 to $17.77 per share on January 27, , respectively to as high as $19.20 per share on January 31, 2020, and declined to as low as $4.60 per share. On March 25, 2020.
On July 23, 2020, NYSE: NNVC shares closed at $6.64 per share.
Those who purchased shares of NanoViricides, Inc. (NYSE: NNVC) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.